Increase in counterfeit drugs a danger to Canadians
As the trade in counterfeit drugs grows, so do the risks to Canadian patients and the costs to legitimate manufacturers
Read More
Author: Kristina Acri
Inadequate intellectual property rights protections hurt patients, economy
Provide biopharmaceutical firms with patent term extensions to recover time lost due to mandatory governmental regulatory and marketing approvals
Read More
Stronger IP protection for biologic medicine could save lives
Biologic medicines are difficult and expensive to develop, and Canadia’s weak intellectual property protections are making it even harder
Read More- 1
- 2